5. POTENTIAL for HUMAN EXPOSURE 5.1 OVERVIEW Otto
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Increased Urinary Nitrate Excretion in Rats with Adjuvant Arthritis
Annals of the Rheumatic Diseases 1994; 53: 547-549 547 Ann Rheum Dis: first published as 10.1136/ard.53.8.547 on 1 August 1994. Downloaded from Increased urinary nitrate excretion in rats with adjuvant arthritis Dirk 0 Stichtenoth, Frank-M Gutzki, Dimitrios Tsikas, Norma Selve, Stefanie M Bode-Boger, Rainer H Boger, Jurgen C Frolich Abstract well established model ofpolyarthritis. For this Objectives-In rats with adjuvant arthritis we applied a recently developed, highly spec measurements were taken of the urinary ific and sensitive gas chromatographic method excretion ofnitrate, reflecting endogenous for determination of nitrite and nitrate in nitric oxide (NO) formation, and cyclic serum, urine, synovia and cell supernatants. guanosine monophosphate (cGMP). NO itself is difficult to measure directly, Methods-Urinary nitrate was deter- because of its very short half life in biological mined by gas chromatography, cGMP by fluids. NO is readily oxidised to nitrite and radioimmunoassay. nitrate,7 which are excreted rapidly into urine. Results-A significant (p < 0.001), more It has been shown, that the major source of than three fold increase of urinary nitrate urinary nitrate, in the absence of excess nitrate excretion was found in rats 20 days after intake in food, is endogenously synthesised induction of adjuvant arthritis compared NO.8 Therefore the NO synthase activity can with non-arthritic rats. There was no be assessed reliably by measuring urinary significant difference in urinary cGMP nitrate excretion, as reported by Suzuki et al9 excretion between arthritic rats and and our group (Bode-Boger et al). control animals. Conclusion-The data suggest that the dramatic increase of urinary nitrate ex- Materials and methods cretion is due to increase of NO synthesis ANIMALS AND ARTHRITIS INDUCTION by the inducible form ofNO synthase. -
WHITE LABEL PRODUCT INGREDIENTS All the Information You Need When Creating Your Own Label Artwork
WHITE LABEL PRODUCT INGREDIENTS All the information you need when creating your own label artwork. SPRAY TAN SOLUTION - LIGHT - 8% DHA INGREDIENTS: Aqua (Water), Dihydroxyacetone, Alcohol, Hamamelis Virginiana (Witch Hazel) Leaf Extract, Propylene Glycol, Caramel, Phenoxyethanol, Caprylyl Glycol, Potassium Sorbate, Hexylene Glycol, Polysorbate 20, Xanthan Gum, Glycerin, T-Butyl Alcohol, Helianthus Annuus (Sunflower) Seed Oil, Beta Vulgaris (Beet) Root Extract, Panthenol, Solanum Lycopersicum (Tomato) Fruit Extract, Vaccinium Macrocarpon (Cranberry) Fruit Extract, Ascorbic Acid (Vitamin C), Tocopheryl Acetate (Vitamin E), Theobroma Cacao (Cocoa) Seed Butter, Rosa Canina (Rose Hip) Fruit Oil, Glycine Soja (Soybean) Oil, Cucumis Sativus (Cucumber) Fruit Extract, Brucine Sulfate, Yellow 5 (CI 19140), Green 5 (CI 61570), Red 40 (CI 16035), Red 33 (CI 17200), Blue 1 (CI 42090), Yellow 6 (CI 15985) SPRAY TAN SOLUTION - MEDIUM - 10% DHA INGREDIENTS: Aqua (Water), Dihydroxyacetone, Alcohol, Hamamelis Virginiana (Witch Hazel) Extract, Propylene Glycol, Caramel, Phenoxyethanol, Caprylyl Glycol, Potassium Sorbate, Hexylene Glycol, Polysorbate 20, Xanthan Gum, Glycerin, T-Butyl Alcohol, Helianthus Annuus (Sunflower) Seed Oil, Beta Vulgaris (Beet) Root Extract, Panthenol, Solanum Lycopersicum (Tomato) Fruit Extract, Vaccinium Macrocarpon (Cranberry) Fruit Extract, Ascorbic Acid (Vitamin C), Tocopheryl Acetate (Vitamin E), Theobroma Cacao (Cocoa) Seed Butter, Rosa Canina (Rose Hip) Fruit Oil, Glycine Soja (Soybean) Oil, Cucumis Sativus (Cucumber) Fruit -
Comparison of Ethylene Glycol and Propylene Glycol Based Aircraft
Comparison of Ethylene Glycol- and Propylene Glycol-Based Aircraft Deicing Fluids Agenda • Executive Summary • Chemistry • Operational Properties (for the aircraft) o Freezing Point (efficiency) o Lowest Operational Use Temperature o Holdover Time and Allowance Times • Mammalian Toxicity o Operator Precautions • Environmental Toxicity o Aquatic Toxicity o Air Emissions / Vapor Pressure o Biodegradation Executive Summary • Both ethylene glycol- (EG) and propylene glycol- (PG) based aircraft deicing fluids (ADFs) consist of the base glycol plus water and additives • Operationally, EG-based fluids perform better: • Less EG is required to produce the same freezing point than PG. • Lower viscosity means EG-based fluids provide better aerodynamic performance at colder temperatures. • As a result, EG-based fluids have superior Holdover Times (HOTs) compared to PG-based fluids, as presented by the SAE G-12 HOT Committee in May 2017. • Mammalian Toxicity • EG and PG both have low to moderate acute toxicity. • If ingested in a large, single oral dose, EG is more toxic to mammals than PG. • Oral dosing is an unlikely route of exposure during deicing. • History in Canada, where EG fluids have been used safely for many years, confirms operator procedures can appropriately manage this risk. Executive Summary • Environmental Properties • EG-based fluids in concentrated form generally demonstrate better aquatic toxicity than PG-based fluids; however, both are non-toxic. • Mixtures of EG-based ADFs exhibit less air emissions than PG based fluids.1 • Both EG and PG are biodegradable in the environment and neither bio accumulates. • PG has higher Theoretical Oxygen Demand and requires a higher usage concentration than PG fluids. -
PROPYLENE GLYCOL from GLYCERIN (December 2007)
Abstract Process Economics Program Report 262 PROPYLENE GLYCOL FROM GLYCERIN (December 2007) A variety of economic, environmental and technical factors have encouraged industry attention on producing industrial chemicals from bio-feedstocks, rather than from crude oil derivatives. One such example is producing propylene glycol (PG) from glycerine (GLY), rather than the conventional routes starting with propylene monomer. Propylene glycol has historically been produced in commercial quantities either via the chlorohydrin process or by peroxidation, both using propylene monomer as the starting material. Both routes produce propylene oxide (PO) as an intermediate chemical, which is then hydrated to propylene glycol. The peroxidation routes have evolved from those processes (Arco Chem/Lyondell, Repsol, Shell, BASF) producing a significant amount of by-product (PO/styrene monomer, PO/tertiary butyl alcohol, PO/ methyl tertiary butyl ether), to more recent processes developed by Solvay, Dow and BASF that eliminate the by-product by using hydrogen peroxide as the oxidizing agent. As of 2007, Degussa has announced the design and construction of a commercial scale PG plant using glycerine as its feedstock. Other companies have announced processes to use glycerine to produce polyols and epichlorohydrin. The combination of high crude oil prices and governmental subsidies to produce biofuels (bio-ethanol, bio-diesel) have resulted in an enormous increase in bio-diesel production, resulting in a glut of by-product glycerine (which represents 10% of biodiesel mass). As a result, glycerine market prices have fallen from $US 2/kg down to fuel value ($US 200/mt), or less. The low cost of glycerine combined with the high price of PG offers an opportunity to develop industrial scale processes converting glycerine to propylene glycol. -
Boiling Points of the Propylene Glycol + Glycerol System at 1 Atmosphere Pressure: 188.6–292 °C Without and with Added Water Or Nicotine
Portland State University PDXScholar Chemistry Faculty Publications and Presentations Chemistry 2018 Boiling Points of the Propylene Glycol + Glycerol System at 1 Atmosphere Pressure: 188.6–292 °c Without and with Added Water or Nicotine Anna K. Duell Portland State University, [email protected] James F. Pankow Portland State University, [email protected] Samantha M. Gillette Portland State University, [email protected] David H. Peyton Portland State University, [email protected] Follow this and additional works at: https://pdxscholar.library.pdx.edu/chem_fac Part of the Chemistry Commons Let us know how access to this document benefits ou.y Citation Details Duell, A. K., Pankow, J. F., Gillette, S. M., & Peyton, D. H. (2018). Boiling points of the propylene glycol + glycerol system at 1 atmosphere pressure: 188.6-292 °C without and with added water or nicotine. Chemical Engineering Communications, 205(12), 1691–1700. https://doi.org/10.1080/ 00986445.2018.1468758 This Post-Print is brought to you for free and open access. It has been accepted for inclusion in Chemistry Faculty Publications and Presentations by an authorized administrator of PDXScholar. Please contact us if we can make this document more accessible: [email protected]. 1 1 Full title: 2 Boiling Points of the Propylene Glycol + Glycerol System 3 at 1 Atmosphere Pressure: 188.6 to 292 °C 4 Short title: 5 Boiling Points: Propylene Glycol + Glycerol 6 7 Anna K. Duell, 1 James F. Pankow,1,2 David H. Peyton1,3 8 1Department of Chemistry, Portland State University, Portland, Oregon, 97207, United States of 9 America 10 2Department of Civil and Environmental Engineering, Portland State University, Portland, 11 Oregon, 97207, United States of America 12 3Corresponding author 13 E-mail: [email protected] (DP) 14 Phone number: 503-725-3875 15 16 Abstract 17 In electronic cigarettes (“electronic nicotine delivery systems”, ENDSs), mixtures of propylene 18 glycol (PG) and/or glycerol (GL; aka “vegetable glycerin”, VG) with nicotine are vaporized to 19 create a nicotine-containing aerosol. -
1. PUBLIC HEALTH STATEMENT This Statement Was Prepared to Give
OTTO FUEL II AND ITS COMPONENTS 1 1. PUBLIC HEALTH STATEMENT This statement was prepared to give you information about Otto Fuel II and its components, and to emphasize the human health effects that may result from exposure to them. The Environmental Protection Agency (EPA) has identified 1,397 hazardous waste sites as the most serious in the nation. These sites make up the National Priorities List (NPL) and are the sites targeted for long-term federal clean-up activities. Otto Fuel II has been found at two of the sites on the NPL. However, the number of NPL sites evaluated for Otto Fuel II and its components is not known. As EPA evaluates more sites, the number of sites at which Otto Fuel II and its components are found may increase. This information is important for you to know because Otto Fuel II and its components may cause harmful health effects and because these sites are potential or actual sources of human exposure to Otto Fuel II and its components. When a chemical is released from a large area, such as an industrial plant, or from a container, such as a drum or bottle, it enters the environment as a chemical emission. This emission, which is also called a release, does not always lead to exposure. You can be exposed to a chemical only when you come into contact with the chemical. You may be exposed to it in the environment by breathing, eating or drinking substances containing the chemical, or from skin contact with it. If you are exposed to a hazardous chemical such as Otto Fuel II and its components, several factors will determine whether harmful health effects will occur, and what the type and severity of those health effects will be. -
Nitroaromatic Antibiotics As Nitrogen Oxide Sources
Review biomolecules Nitroaromatic Antibiotics as Nitrogen Oxide Sources Review Allison M. Rice, Yueming Long and S. Bruce King * Nitroaromatic Antibiotics as Nitrogen Oxide Sources Department of Chemistry and Biochemistry, Wake Forest University, Winston-Salem, NC 27101, USA; Allison M. Rice , Yueming [email protected] and S. Bruce (A.M.R.); King [email protected] * (Y.L.) * Correspondence: [email protected]; Tel.: +1-336-702-1954 Department of Chemistry and Biochemistry, Wake Forest University, Winston-Salem, NC 27101, USA; [email protected]: Nitroaromatic (A.M.R.); [email protected] antibiotics (Y.L.) show activity against anaerobic bacteria and parasites, finding * Correspondence: [email protected]; Tel.: +1-336-702-1954 use in the treatment of Heliobacter pylori infections, tuberculosis, trichomoniasis, human African trypanosomiasis, Chagas disease and leishmaniasis. Despite this activity and a clear need for the Abstract: Nitroaromatic antibiotics show activity against anaerobic bacteria and parasites, finding usedevelopment in the treatment of new of Heliobacter treatments pylori forinfections, these conditio tuberculosis,ns, the trichomoniasis, associated toxicity human Africanand lack of clear trypanosomiasis,mechanisms of action Chagas have disease limited and their leishmaniasis. therapeutic Despite development. this activity Nitroaro and a clearmatic need antibiotics for require thereductive development bioactivation of new treatments for activity for theseand this conditions, reductive the associatedmetabolism toxicity can convert -
Nitric Oxide Activates Guanylate Cyclase and Increases Guanosine 3':5'
Proc. Natl. Acad. Sci. USA Vol. 74, No. 8, pp. 3203-3207, August 1977 Biochemistry Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations (nitro compounds/adenosine 3':5'-cyclic monophosphate/sodium nitroprusside/sodium azide/nitrogen oxides) WILLIAM P. ARNOLD, CHANDRA K. MITTAL, SHOJI KATSUKI, AND FERID MURAD Division of Clinical Pharmacology, Departments of Medicine, Pharmacology, and Anesthesiology, University of Virginia, Charlottesville, Virginia 22903 Communicated by Alfred Gilman, May 16, 1977 ABSTRACT Nitric oxide gas (NO) increased guanylate cy- tigation of this activation. NO activated all crude and partially clase [GTP pyrophosphate-yase (cyclizing), EC 4.6.1.21 activity purified guanylate cyclase preparations examined. It also in- in soluble and particulate preparations from various tissues. The effect was dose-dependent and was observed with all tissue creased cyclic GMP but not adenosine 3':5'-cyclic monophos- preparations examined. The extent of activation was variable phate (cyclic AMP) levels in incubations of minces from various among different tissue preparations and was greatest (19- to rat tissues. 33-fold) with supernatant fractions of homogenates from liver, lung, tracheal smooth muscle, heart, kidney, cerebral cortex, and MATERIALS AND METHODS cerebellum. Smaller effects (5- to 14-fold) were observed with supernatant fractions from skeletal muscle, spleen, intestinal Male Sprague-Dawley rats weighing 150-250 g were decapi- muscle, adrenal, and epididymal fat. Activation was also ob- tated. Tissues were rapidly removed, placed in cold 0.-25 M served with partially purified preparations of guanylate cyclase. sucrose/10 mM Tris-HCl buffer (pH 7.6), and homogenized Activation of rat liver supernatant preparations was augmented in nine volumes of this solution by using a glass homogenizer slightly with reducing agents, decreased with some oxidizing and Teflon pestle at 2-4°. -
Nitroglycerin Sublingual Tablets, USP)
NDA 021134/S-004 Page 4 Nitrostat® (Nitroglycerin Sublingual Tablets, USP) DESCRIPTION Nitrostat is a stabilized sublingual compressed nitroglycerin tablet that contains 0.3 mg , 0.4 mg , or 0.6 mg nitroglycerin; as well as lactose monohydrate, NF; glyceryl monostearate, NF; pregelatinized starch, NF; calcium stearate, NF powder; and silicon dioxide, colloidal, NF. Nitroglycerin, an organic nitrate, is a vasodilating agent. The chemical name for nitroglycerin is 1, 2, 3 propanetriol trinitrate and the chemical structure is: NO2 O O N O CH2CHCH2 O NO 2 2 C3H5N309 Molecular weight: 227.09 CLINICAL PHARMACOLOGY The principal pharmacological action of nitroglycerin is relaxation of vascular smooth muscle. Although venous effects predominate, nitroglycerin produces, in a dose-related manner, dilation of both arterial and venous beds. Dilation of postcapillary vessels, including large veins, promotes peripheral pooling of blood, decreases venous return to the heart, and reduces left ventricular end-diastolic pressure (preload). Nitroglycerin also produces arteriolar relaxation, thereby reducing peripheral vascular resistance and arterial pressure (afterload), and dilates large epicardial coronary arteries; however, the extent to which this latter effect contributes to the relief of exertional angina is unclear. Therapeutic doses of nitroglycerin may reduce systolic, diastolic, and mean arterial blood pressure. Effective coronary perfusion pressure is usually maintained, but can be compromised if blood pressure falls excessively, or increased heart rate decreases diastolic filling time. Elevated central venous and pulmonary capillary wedge pressures, and pulmonary and systemic vascular resistance are also reduced by nitroglycerin therapy. Heart rate is usually slightly increased, presumably due to a compensatory response to the fall in blood pressure. -
Mechanisms of Nitric Oxide Reactions Mediated by Biologically Relevant Metal Centers
Struct Bond (2014) 154: 99–136 DOI: 10.1007/430_2013_117 # Springer-Verlag Berlin Heidelberg 2013 Published online: 5 October 2013 Mechanisms of Nitric Oxide Reactions Mediated by Biologically Relevant Metal Centers Peter C. Ford, Jose Clayston Melo Pereira, and Katrina M. Miranda Abstract Here, we present an overview of mechanisms relevant to the formation and several key reactions of nitric oxide (nitrogen monoxide) complexes with biologically relevant metal centers. The focus will be largely on iron and copper complexes. We will discuss the applications of both thermal and photochemical methodologies for investigating such reactions quantitatively. Keywords Copper Á Heme models Á Hemes Á Iron Á Metalloproteins Á Nitric oxide Contents 1 Introduction .................................................................................. 101 2 Metal-Nitrosyl Bonding ..................................................................... 101 3 How Does the Coordinated Nitrosyl Affect the Metal Center? .. .. .. .. .. .. .. .. .. .. .. 104 4 The Formation and Decay of Metal Nitrosyls ............................................. 107 4.1 Some General Considerations ........................................................ 107 4.2 Rates of NO Reactions with Hemes and Heme Models ............................. 110 4.3 Mechanistic Studies of NO “On” and “Off” Reactions with Hemes and Heme Models ................................................................................. 115 4.4 Non-Heme Iron Complexes .......................................................... -
NITROGYLCERIN and ETHYLENE GLYCOL DINITRATE Criteria for a Recommended Standard OCCUPATIONAL EXPOSURE to NITROGLYCERIN and ETHYLENE GLYCOL DINITRATE
CRITERIA FOR A RECOMMENDED STANDARD OCCUPATIONAL EXPOSURE TO NITROGYLCERIN and ETHYLENE GLYCOL DINITRATE criteria for a recommended standard OCCUPATIONAL EXPOSURE TO NITROGLYCERIN and ETHYLENE GLYCOL DINITRATE U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service Center for Disease Control National Institute for Occupational Safety and Health June 1978 For »ale by the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402 DISCLAIMER Mention of company name or products does not constitute endorsement by the National Institute for Occupational Safety and Health. DHEW (NIOSH) Publication No. 78-167 PREFACE The Occupational Safety and Health Act of 1970 emphasizes the need for standards to protect the health and provide for the safety of workers occupationally exposed to an ever-increasing number of potential hazards. The National Institute for Occupational Safety and Health (NIOSH) evaluates all available research data and criteria and recommends standards for occupational exposure. The Secretary of Labor will weigh these recommendations along with other considerations, such as feasibility and means of implementation, in promulgating regulatory standards. NIOSH will periodically review the recommended standards to ensure continuing protection of workers and will make successive reports as new research and epidemiologic studies are completed and as sampling and analytical methods are developed. The contributions to this document on nitroglycerin (NG) and ethylene glycol dinitrate (EGDN) by NIOSH staff, other Federal agencies or departments, the review consultants, the reviewers selected by the American Industrial Hygiene Association, and by Robert B. O ’Connor, M.D., NIOSH consultant in occupational medicine, are gratefully acknowledged. The views and conclusions expressed in this document, together with the recommendations for a standard, are those of NIOSH. -
Acetyl Tributyl Citrate | C20H34O8 - Pubchem
12/31/2020 Acetyl tributyl citrate | C20H34O8 - PubChem COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: https://www.coronavirus.gov. Get the latest research from NIH: https://www.nih.gov/coronavirus. COMPOUND SUMMARY Acetyl tributyl citrate PubChem CID 6505 Structure 2D Find Similar Structures Chemical Safety Laboratory Chemical Safety Summary (LCSS) Datasheet Molecular Formula C20H34O8 ACETYL TRIBUTYL CITRATE 77-90-7 tributyl 2-acetoxypropane-1,2,3-tricarboxylate Synonyms Tributyl O-acetylcitrate Acetyltributyl citrate More... Molecular Weight 402.5 g/mol Modify Create Dates 2020-12-26 2005-03-26 https://pubchem.ncbi.nlm.nih.gov/compound/6505 1/46 12/31/2020 Acetyl tributyl citrate | C20H34O8 - PubChem 1 Structures 1.1 2D Structure Chemical Structure Depiction PubChem 1.2 3D Status Conformer generation is disallowed since too flexible PubChem https://pubchem.ncbi.nlm.nih.gov/compound/6505 2/46 12/31/2020 Acetyl tributyl citrate | C20H34O8 - PubChem 2 Names and Identifiers 2.1 Computed Descriptors 2.1.1 IUPAC Name tributyl 2-acetyloxypropane-1,2,3-tricarboxylate Computed by LexiChem 2.6.6 (PubChem release 2019.06.18) PubChem 2.1.2 InChI InChI=1S/C20H34O8/c1-5-8-11-25-17(22)14-20(28-16(4)21,19(24)27-13-10-7-3)15-18(23)26-12-9-6-2/h5-15H2,1-4H3 Computed by InChI 1.0.5 (PubChem release 2019.06.18) PubChem 2.1.3 InChI Key QZCLKYGREBVARF-UHFFFAOYSA-N Computed by InChI 1.0.5 (PubChem release 2019.06.18) PubChem 2.1.4 Canonical SMILES CCCCOC(=O)CC(CC(=O)OCCCC)(C(=O)OCCCC)OC(=O)C Computed